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Abstract 
Very few discrete-event simulation studies follow up on recommendations with evaluation of 
whether modelled benefits have been realised and the extent to which modelling contributed to any 
change.  This paper evaluates changes made to the emergency stroke care pathway at a UK hospital 
informed by a simulation modelling study.  The aims of the study were to increase the proportion of 
people with strokes that undergo a time-sensitive treatment to breakdown a blood clot within the 
brain and decrease the time to treatment.  Evaluation involved analysis of stroke treatment pre- and 
post- implementation, as well as a comparison of how the research team believed the intervention 
would aid implementation compared to what actually happened.  Two years after the care pathway 
was changed, treatment rates had increased in line with expectations and the hospital was treating 
four times as many patients than before the intervention in half the time.  There is evidence that the 
modelling process aided implementation, but not always in line with expectations of the research 
team.  Despite user involvement throughout the study it proved difficult to involve a representative 
group of clinical stakeholders in conceptual modelling and this affected model credibility.  The 
research team also found batch experimentation more useful than visual interactive simulation to 
structure debate and decision making.  In particular, simple charts of results focused debates on the 
clinical effectiveness of drugs - an emergent barrier to change. Visual interactive simulation proved 
more useful for engaging different hospitals and initiating new projects.   
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1. Introduction 
This paper describes the implementation and evaluation of changes to an emergency stroke care 
pathway in a large acute hospital within the United Kingdom.  These changes followed a discrete-
event simulation (DES) study that was undertaken to both identify improvement opportunities and 
support the implementation of improvement between the clinical stakeholders in the pathway.  The 
aim of the intervention was to increase the proportion of patients with acute ischaemic stroke that 
receive a time sensitive treatment to break down a blood clot within an artery in the brain 
(thrombolysis with the drug alteplase).  The full technical details of the simulation model are 
published elsewhere [1].  The purpose of this paper is to evaluate the impact of the study in 
improving the real-world system. We define impact in three ways: did the results of the model 
influence decision making in the context of the problem; did the changes implemented improve real 
world performance as defined in the project; and did the modelling intervention/process influence 
the chances of implementation as the research team expected. The evaluation of impact was 
conducted using a two-stage methodology: an analysis of data pre and post implementation and a 
comparison of how the research team believed the intervention would aid implementation 
compared to what actually happened.  
The DES literature contains many case studies of computer models that compare alternative policies 
to identify costs and efficiency savings within industry  [2] and healthcare [3].   While these case 
studies are numerous the evidence that such modelling leads to the implementation of simulation 
results is lacking.  Although not exclusively limited to a particular domain, this lack of 
implementation evidence has been particularly well documented in systematic reviews within 
healthcare DES modelling [3-7].  Notably, over the period of 12 years spanning the publication of 
these reviews only a small number of studies describing the implementation of simulation results in 
healthcare have been published [e.g. 8, 9].  
Evaluations of implementation processes are increasingly conducted in other areas of health services 
research such as health technology assessment [10] and health program evaluation [11], but are rare 
in Operational Research (OR).  A plausible reason for the apparent lack of implementation accounts 
and follow up evaluation is the tension between the time needed to implement change within an 
organization and the timescale for publication of model results; although it is arguable that such a 
tension is not unique to DES and OR.  One reason that may be specific to OR is the tension between 
what is seen as legitimate research and what is consultancy [12].  Academics in OR gain little reward 
for publishing relatively standard models using text book methodology, although implementing 
results of such models may be of great help to organisations.  On the other hand, evaluation 
research is valuable to the academic community, particularly in the context of increasing recognition 
of the need to value the positive impact of research in society.  Not only does evaluation 
demonstrate effectiveness or issues with use of methods, but it at its core challenges researchers to 
revisit and test their assumptions about how they expect a modelling intervention to work [13].  A 
larger evidence base in the area of evaluation should lead to improved methodology for conducting 
modelling interventions using methods such as DES. 
The contributions of this study are therefore threefold: evidence that the results of healthcare DES 
modelling interventions are implemented in practice; quantitative evidence that changes 
recommended by DES can lead to real system improvement and improved stroke patient outcomes; 
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and revised propositions about how simulation modelling interventions aid the changes of 
implementation.  
The paper begins with the background to the simulation study including an overview of the model, 
expected performance, the changes implemented, and how the research team believed the 
intervention would work.  We then present the results of a quantitative evaluation confirming that 
the hospital has seen substantial improvement following the study.  This is followed by a qualitative 
comparison of how the research team believed the intervention would support implementation 
compared to what actually happened.  The final section draws together the qualitative and 
quantitative aspects of the evaluation and assesses the accuracy of how the research team believed 
the intervention would work.  Final comments discuss the need for systematic research into the 
implementation of results from similar projects. 
2. Background to the simulation study 
2.1. Thrombolysis for Acute Ischaemic Stroke 
Ischaemic events account for over 80% of all cases of stroke [14].  The only licensed treatment for 
acute ischaemic stroke is thrombolysis with alteplase, a treatment intended to restore blood flow 
within an artery occluded by thrombus (blood clot).  Due to the high metabolic demands of brain 
tissue, the effectiveness of thrombolysis is critically time dependent [15, 16]. The earlier a patient 
receives treatment the greater the chances of recovery with minimal or no disability, such that the 
effectiveness of the treatment halves with each 90 minute period that passes from onset [17].  As 
with all drug treatments there are also risks.  In this case treatment increases the risk of 
symptomatic intracranial haemorrhage (SIH: bleeding within the brain), that often leads to death.  
However, when treatment is given within 6 hours of onset, the accumulated evidence shows that 
the benefit of stroke thrombolysis in reducing disability outweighs the risk of intracranial 
haemorrhage [16, 18]. 
In Europe, alteplase was originally licensed in 2003 for use within a three hour period from the onset 
of ischaemic stroke.  In that time the patient needs to travel to hospital and be assessed and treated 
in an emergency department (ED), including brain imaging.  Uptake of the treatment has been slow, 
often because of difficulties with completing the diagnostic process within the short time window, 
with between 3.5-5% of patients receiving the treatment [19].  Efforts to increase this proportion 
have focused on two areas: randomised controlled trials (RCTs) assessing the efficacy of extending 
alteplase treatment from three to four and a half hours (or beyond); and public education campaigns 
to increase awareness of stroke symptoms (e.g. the act FAST campaign in the UK) in order to 
encourage earlier presentation to hospital with suspected stroke.   The benefit of thrombolysis is 
measured in terms of the increase in the proportion of patients with minimal or no disability at 
follow-up (usually 90 days), attributed a modified Rankin Scale (mRS) score of 0 or 1 (the mRS is an 
ordinal scale of disability scoring between 0 (no symptoms or disabilities) and 6  [death; 20, 21]. 
2.2. The modelling intervention 
Similar to many other hospitals in the UK and elsewhere our hospital treated 4-5% of all acute 
strokes annually with alteplase, with the majority of treatment delivered close to the three-hour 
treatment deadline.   The project reported here was initiated in late 2010 as a collaboration 
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between hospital clinicians and medical school academics to investigate the most effective 
operational changes that could be made to increase thrombolysis rates and reduce stroke-related 
disability.  We chose to use DES to model the stroke pathway as we believed it represented a 
compromise between the expert and facilitative modes of engagement with stakeholders [22] that 
others have described as pseudo-facilitative [23].  We chose this approach based on three core 
beliefs.  First, we believed that in order to achieve any agreement on change within the hospital we 
needed to operate in the facilitative mode of engagement during conceptual modelling [24]; aiding 
the relevance, transparency and credibility of results to the stakeholders’ problem.  Second, DES 
provides the opportunity to use visual interactive simulation (VIS).  We believed that VIS would 
increase the engagement of stakeholders, enabling validation and experimentation, thereby 
improving the transparency of the model, both of which are prerequisites for effective 
implementation [25].  Third, we believed that modelling in general would provide a common 
reference point and structure debate between stakeholders with competing interests. These three 
hypotheses represent how the research team expected the modelling intervention to support the 
implementation of the results of the DES study.  The final section of this paper reflects on these 
hypotheses and evaluates if these assumptions were indeed the key factors that aided 
implementation. 
2.3. The simulation model 
The DES model focuses on the emergency phase of the stroke pathway.  Other modelling studies of 
stroke care and discussions of their potential benefits have been published [26-33], but none 
provide any details of implementation or health impact.  For brevity this section provides a high level 
description of the model.  More detail on model inputs and logic pathways can be found in the 
online supplementary material; details to fully replicate the model can be found elsewhere [1]. 
2.3.1. Model logic  
The model is divided into four sections: a pre-hospital phase, an ED phase, a referral phase, and a 
phase where the acute stroke team (AST) takes responsibility for the patient.  The main problem 
identified at the project hospital was that in many cases the referral phase was delayed.  That is, 
patients with suspected stroke arriving at the hospital were subject to the common delays in triage 
and assessment experienced in busy EDs and became ineligible for the time sensitive treatment.  A 
key component of the process is emergency brain imaging with a CT scan (during the AST phase).  
This is used to rule out brain haemorrhage as the cause of stroke.  Two key components of the in-
hospital delay to assessment and treatment that were simulated were the time from arrival to CT 
scan (ATS) and from scan to treatment.  A full pathway diagram is included in the online 
supplementary material. 
2.3.2. Outputs 
The model was used to explore the impact of different configurations of the stroke pathway in terms 
of thrombolysis rates, time to treatment, urgent clinical workload and ultimately patient disability at 
90 days.  Disability measures were represented as the number of additional patients with a 90-day 
mRS of 0-1 attributable to treatment (as some patients will recover without treatment). 
2.3.3. Experimental factors 
The main experimental factors were the paramedic pre-alert rate (where paramedics phone ahead 
alerting clinicians to the imminent arrival of a patient with suspected stroke), ED triage referral rate 
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(where triage nurses contact the AST as they encounter patients with suspected stroke), the time 
window and the likelihood of further contra-indications to treatment, most notably intracerebral 
haemorrhage.  The inclusion of paramedic pre-alerts and early referral at triage were chosen as they 
provide the earliest possible points for emergency referral to the AST.  Paramedic pre-alerts, in most 
instances, allow for a specialist stroke nurse practitioner to meet patients with suspected stroke at 
the doors of the ED.   The inclusion of contra-indications was not a practical implementation aspect 
to explore, but it is an important parameter to help quantify the uncertainty in our model outputs.   
2.3.4. Summary of model results 
Model results were presented to the clinical stakeholders using a standard pairwise comparison 
approach for scenarios [34], particularly making use of graphical plots to communicate differences.  
Here we focus on the uncertainty in the model results.  To illustrate the results of the model we 
include a 23 factorial design including two of the early referral parameters and the proportion of 
exclusions between midnight and 11am (due to our concern about underestimating the proportion 
of ‘wake-up’ strokes where the onset time is unknown).  Full results, main and interaction effects are 
provided in the online supplementary material.  
The range of uncertainty for the overall thrombolysis rate was predicted to be between 7.9 and 
14.2% of patients.  More importantly, the results demonstrated the critical importance of high 
compliance with the referral protocol by paramedics and at ED triage.  Low compliance in one while 
the other is high was expected to reduce the proportion treated by 1.1% (95% CI 1.0-1.3%).  As such, 
the study recommended that the hospital and the local ambulance service implement robust 
protocols for pre-alerts both pre-hospital and within ED. 
2.4. Implementation of results 
The development of the model and its use took place over six months (January - June 2011).  
Implementation took place over the following year and was led by the AST with support provided by 
a simulation modeller.  The project timeline is illustrated by Figure 1.  Implementation of the results 
of the study was phased: from December 2011 (phase 1) stroke patients were referred from ED 
triage directly to the AST, and from August 2012 (phase 2) paramedics began phoning the AST to 
alert them prior to suspected stroke arrivals in the ED.  In addition to the recommendations of the 
DES study the hospital also extended the alteplase protocol to treat patients over the age of 80 from 
May 2012 following the publication of a large randomised controlled trial [35] 
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Figure 1: Study and Implementation Timeline† 
†Diamonds represent important project milestones 
3. Quantitative evaluation 
We follow the overview of the simulation study with a quantitative evaluation comparing stroke 
thrombolysis pre and post-implementation.  The post-implementation data cover a period of 21 
months.  This section summarises the study design (the full protocol can be found in the 
supplementary appendix) and presents the results.   
3.1. Study Design 
Four treatment variables are evaluated using a pre-intervention post-intervention design: the time 
taken from a patient arriving at hospital to brain scanning (ATS), the time taken from arrival to 
treatment (ATT), the thrombolysis rate (the number of patients receiving thrombolysis as a 
proportion of the total number of strokes in the time period) and the number of adverse events 
including SIH.   We also measured compliance with the early referral protocols.  Data were collected 
prospectively from 01/01/11 until 31/08/13.  Statistical tests are described in the online 
supplementary material. 
3.2. Results 
3.2.1. Participants 
Detailed thrombolysis data were available from 2007 until September 2013.  We limited the analysis 
of thrombolysis rates in the pre-implementation period to between 01/01/09 and 30/11/11, as 
absolute numbers of thrombolysed patients were notably lower prior to 2009.  The post-
implementation period ranged from 01/12/11 until 31/08/13.  In total this provided 2930 cases of 
stroke (1851 pre and 1088 post-implementation).  Figure illustrates this breakdown in more detail.   
 
Nov-10 Sep-13
Jan-11
Apr-11 Jul-11 Oct-11 Jan-12 Apr-12 Jul-12 Oct-12 Jan-13 Apr-13 Jul-13
Dec 11 - Aug 13
Evaluation Study Period
Jan 11 - Feb 11
Problem Structuring
Nov-10
Preliminary investigation by MS, AST & ED
Jul-11
Simulation Results Reported
Dec-11
Triage referral implemented
Aug-12
Stroke phone protocol implemented
May-12
Trial results extend eligibility to over 80s
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Before 
n = 1851
Thrombolysed
n = 87 (4.7%)
<= 80 years
N = 74 (4.0%)
> 80 years
N = 13 (0.7%)
ED arrivals
N = 71 (3.8%) 
In-patients
N = 3 (0.2%)
Total Strokes
n = 2939
Not treated
n = 1764
ED arrivals
N = 12 (0.6%)
In-patients
N = 1 (0.1%)
After 
n = 1088
Thrombolysed
n = 125 (11.5%)
<= 80 years
N = 83 (7.6%)
> 80 years
N = 42 (3.9%)
ED arrivals
N = 75 (6.9%) 
In-patients
N = 8 (0.7%)
Not treated
n = 963
ED arrivals
N = 41 (3.8%)
In-patients
N = 1 (0.1%)
 
Figure 2: Breakdown of sample used in analysis of thrombolysis rate. 
 
3.2.2. Main Results 
The total proportion of strokes thrombolysed pre-implementation was 4.7% compared to 11.5% 
post-implementation.   After exclusion of the over 80s and in-patient strokes these figures fall to 
3.8% and 6.9%, respectively; giving an absolute increase in thrombolysis rates of 3.1% (95% CI 1.3% 
to 4.7%).  Average ATS fell by 24.7 minutes (95% CI 17.5-31.8) with overall average ATT falling by a 
similar amount (26.3 mins; 95% CI 17.7-35.1).   A substantial impact of the change occurs in the tail 
of the distribution where the 90th percentile was reduced from 145.0 minutes (95% CI 126.4-164.0) 
to 102.9 minutes (95% CI 91.1-115.0) a difference of 42.1 minutes (95% CI 18.0-68.1).  There were 
four adverse events in 2011 of which three were SIH (7%) and six adverse events post-
implementation of which three were SIH (3%).  Table 1 summarises these main outcomes. 
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Table 1: Summary of main outcomes 
 Pre  Post  
Arrival to Scan times   
N  100 107 
Mean (SD) 58 (30) 33 (20) 
Median (IQR) 51 (37) 27 (26) 
10th Percentile 25 12 
90th Percentile 107 63 
   
Arrival to Treatment times   
N 93 106 
Mean (SD) 90 (35) 63 (26) 
Median (IQR) 85 (46) 58 (35) 
10th Percentile 51 36 
90th Percentile 145 102 
   
Thrombolysis rate   
All Stroke cases 1851 1088 
Thrombolysed cases 87 (4.7%) 125 (11.5%) 
Thrombolysed cases excluding 
over 80s and inpatients 
73 (3.9%) 75 (6.9%) 
 
3.2.3. Subgroup analyses 
Before the modelling study took place average ATT appeared to be increasing.  Average ATT was 
notably higher in 2010/11 (101 minutes; 95% CI 90.1-111.2) compared to period preceding 2010 (76 
minutes; 95% CI 67.7 – 83.5); skewing improvement estimates.  We therefore conducted a subgroup 
analysis limiting analysis of ATT to patients treated between 01/01/2010 and 31/08/2013; giving a 
difference in average treatment speed of 37 minutes (95% CI 25.7-48.9) following implementation. 
Figure 3 illustrates the thrombolysis rate by half yearly interval starting from mid-2007 (July to 
September 2013 not shown).  When results are limited to phase 2 of implementation (from August 
2012) the hospital achieves its highest thrombolysis rates: 14.5% overall, 11.0% excluding patients 
over 80.   ATT times continued to fall in this time period reaching an average of 55.5 minutes (95% CI 
46.5 – 64.5); a reduction of nearly 50% compared to 2010/11. 
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Figure 3: Thrombolysis rate by half yearly interval 
 
3.2.4. Adherence to paramedic stroke referral protocol 
A total of 671 patients with a diagnosis of stroke were admitted after phase 2 implementation; 504 
of these arrived by ambulance.  Cases of suspected stroke are identified by ambulance paramedics 
using the Face, Arms, Speech and Time (FAST) test.  Given that average FAST diagnostic sensitivity 
has a 95% confidence interval of 76%-85% [36], we estimate that between 383 and 433 of these 
patients would be identified by paramedics en route to hospital (assuming that a diagnostic test was 
applied in all cases). 
A total of 201 pre-alerts were received post phase 2.  Using the estimated FAST positive numbers we 
converted this figure into an average adherence to the pre-alert protocol of 46% (201/433) to 52% 
(201/383).  These figures are skewed by the gradual effect of dissemination in the months following 
the protocol implementation.  If all 2012 data are excluded, adherence rises to 63% to 71%. 
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4. Qualitative evaluation 
Drawing on our knowledge of the involvement hypothesis in the DES and System Dynamics (SD) 
literature [37] and experiential knowledge from clinical practice, we developed three hypotheses 
that reflected our belief in the importance of adopting a facilitative approach and involving clients in 
modelling.  
Hypothesis one draws from the PartiSim (Participative Simulation) framework for healthcare 
simulation [24].  Involvement of clients from different parts of the system in conceptual modelling is 
reported to increase the credibility of results as objective and the modelling process are clearer to 
clients.  Although we ran workshops involving a group of stakeholders in conceptual modelling, we 
chose not to adopt the full Soft Systems Methodology (SSM) approach advocated in the PartiSim 
framework in favour of simpler brainstorming and process mapping exercises.   
Hypothesis two reflects one of the core rationales for VIS. If system behaviour is communicated to 
clients as a model runs, either for validation or experimentation, then this is proposed to facilitate 
trust in the model and results and hence increases the changes that results are implemented [25, 
38]. 
The final hypothesis is based on reported benefits of engaging clients in facilitative modelling [22].  
Although often associated with problem structuring methods, for example SSM [39] or Strategic 
Options Decision Analysis [40], facilitative approaches have been shown to be feasible in DES studies 
[38, 41, 42], for example SimLean facilitate [42], and Group Model Building in SD [43].  The process 
of developing a model is often argued to foster the development of a common language or point of 
reference for stakeholders that improves the quality of debates about action [44]. 
Stated concisely, our three hypotheses were: 
 If stakeholders are involved in conceptual modelling then the relevance, transparency and 
credibility of results to stakeholders are increased. 
 If stakeholders can be engaged by VIS in validation and experimentation then the resulting 
model transparency of working relationships increase the use of results  
 If stakeholders with competing interests are engaged in a modelling project then debate 
about implementation is structured by the model acting as a common reference point. 
This section provides a qualitative evaluation of implementation by comparing these hypotheses to 
what actually happened in the intervention.  Data collection was through the lead modeller’s field 
notes (TM).  In instances where the modeller was leading a meeting, for example when validating 
the model, conversation was recorded and field notes were made afterwards.  In more sensitive 
meetings, i.e. those discussing implementation, conversations were not recorded and notes were 
made from memory immediately following the meeting. 
 
4.1. Hypothesis one: user involvement in conceptual modelling 
The acute stroke team (AST), which is comprised of stroke physicians and specialist nurse 
practitioners, approached the medical school to initiate the intervention and were subsequently 
heavily involved throughout the study. We also believed that conceptual modelling should involve 
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the ED, as a substantial part of the emergency pathway (and controllable processes) occurred there.  
We did not involve the ambulance service in conceptual modelling at the outset, but provided them 
with provisional results once available. 
4.1.1. Involving the ED 
We engaged the clinical lead of the ED at project initiation, as it was felt that he would represent the 
views of the wider group of consultants in ED.  The preliminary project meeting took place in 
October 2010 and was used to define clear performance measures and scenarios from the outset. In 
attendance were a modeller from the medical school, the clinical lead of the ED and the stroke 
physician who would act as the project liaison between the medical school and the hospital.  The ED 
clinical lead was involved in making two key contributions to the conceptual model: key 
performance measures would include the proportion of strokes treated and treatment speed from 
arrival at the hospital; while scenarios should compare the impact of early referral after triage to 
that of extending the license window for thrombolysis from 3 to 4.5 hours after onset.  The meeting 
ended with an agreement that the AST would lead the project and report the results of the 
modelling back to the ED. 
4.1.2. Involving the AST 
The AST added further model outputs and experimental factors to the conceptual model in the early 
part of 2011.  There were two new key performance measures to include: the increase in prioritised 
scans (to assess workload changes) and the number of patients with minimal or no disability at 90 
days due to treatment.  The lead AST clinician felt that the latter measure was less abstract than 
time to treatment and would be important when communicating the results to the wider clinician 
audience and the ambulance service.  The AST, particularly the specialist nurse practitioners, were 
also involved in process mapping and model validation workshops.  This prompted a further 
experimental factor to be added to the model: the rate at which paramedics’ pre-alert the AST to 
imminent stroke arrivals.   
Implementation of a pre-alert system was thought to be plausible, as ambulance crews already 
provided pre-alerts to the ED for other emergency conditions.  A potential barrier to implementation 
was thought to be a change of control in the pathway; i.e. a move from the ED to the AST.  A 
plausible solution was to design an information chain: where the ambulance crews pre-alert the ED 
and then the ED passes the information to the AST.  Although some information would risk being lost 
in such a system, it was believed that the wider group of ED consultants were more likely to agree to 
implementation on these terms.  There was also some concern that prioritized brain scanning might 
lead to many false positives, typically identified by an ED consultant, consuming resources that 
would be better served elsewhere.  As such, the scenarios were designed to include specialist 
assessment by an AST nurse prior to brain scanning. 
4.1.3. Influence on implementation 
The modelling was completed in six months with results reported to the AST and ambulance service 
shortly afterwards.  Although engaged at a relatively late stage, the reaction from the ambulance 
service was supportive, observing that it was quite rare to get any feedback on what they as 
paramedics can do to influence patient outcomes.  They stated that the outputs from the model 
allowed them to see what disability impacts might be if they pushed for high pre-alert rates for all 
FAST test positive cases of suspected stroke - an area where it is typically very difficult to make any 
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difference.  Interest was such that the ambulance service were keen to work more closely with the 
medical school to investigate factors during ambulance callout, pickup and travel that might help 
increase treatment rates further. 
While we were able to quickly disseminate the results to the AST and ambulance service, we were 
unable to organise a meeting with the ED until five months after the modelling was completed.  The 
meeting included all consultants from the ED (including the clinical lead) and was led by the AST with 
the medical school providing support regarding the modelling.  
The initial reaction of a subgroup of ED consultants to the modelling results was negative.  
Discussion of the model assumptions revealed that this group had concerns about the evidence base 
for thrombolysis and had further concern about the increased proportion of patients suffering SIH 
leading to higher mortality rates - a measure that was not modelled explicitly (our mRS 0-1 measure 
implicitly incorporates those patients suffering SIH and going on to have good functional outcome).  
This was a surprising reaction, given our previous experience with the ED clinical lead and that the 
most up to date evidence clearly supported the opposite view on the value of thrombolysis [15].  It 
was apparent that the emergency medicine literature took a different position on acute stroke 
thrombolysis to the neurology literature.  In particular, the re-analysis of an early RCT by an 
opponent of thrombolysis argued that there was no evidence of a time dependent benefit [45], 
although this work was subsequently disputed [46]. 
Our conceptual model, therefore, was missing a key output measure: the proportion of patients 
suffering early SIH due to treatment.  We did however have a simple model of SIH available: we 
expect that 4-7% of treated patients will suffer this complication [18].  We had not included this in 
the model as there was no evidence that SIH was related to onset to treatment times.  Nonetheless, 
this exclusion affected study credibility among the ED clinicians. 
With regard to the control of the pathway and screening of false positives before brain scanning, the 
reaction was more positive.  The consensus from the ED clinicians was that implementation would 
work more smoothly if pre-alerts went directly to the AST.  This was due to the high number of pre-
alerts the ED already received for a variety of emergencies, and recognition that reducing the 
information chain meant a more robust solution.  Our design for screening for false positives by AST 
prior to any brain scanning was also acceptable to the ED consultants, recognising the specialist 
knowledge of the AST specialist nurses.   
The outcome of the meeting was positive and swift.  The ED clinical lead contacted the AST the 
following week (December 2011) and confirmed that the ED would go ahead with a change in the 
pathway.  In summary, we found that involvement of stakeholders in conceptual modelling did help 
with the relevance of findings leading to implementation; however, selection bias meant that 
stakeholders did not represent the full range of views on change. 
4.2. Hypothesis two: VIS 
We primarily used VIS during model development between March and June 2011.  Although this was 
originally planned to facilitate both validation and experimentation it was mainly used by the lead 
modeller for the former.  Much of the discussion was therefore of benefit to the modeller rather 
than the stakeholders and does not support the original assumption.  For example, a specialist nurse 
would be shown a simulated patient arriving at different times of the day to illustrate how the model 
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passed information about the patient between clinical groups.  The nurse would then help clarify the 
order of information exchange.   
In contrast to VIS the batch run results provoked more lively responses from stakeholders and 
prompted discussions of implementation.  As we have already reported, both the ambulance service 
and ED were responsive to simple charts illustrating the differences in system performance across 
scenarios (for very different reasons).     
We also used VIS after project completion (July 2011 onwards) to illustrate the simulation approach 
to other hospitals.  As the results of the simulation study were disseminated throughout the regional 
stroke network the medical school was approached by four further trusts (three hospitals and the 
ambulance service) with interest in implementing similar simulation projects within their trust.  We 
met with each of these trusts and visually demonstrated the model and scenario comparison.  In 
these cases the use of VIS achieved more engagement and discussion of possible implementation 
options at the trust. Between December 2011 and January 2013, simulation modelling was 
conducted with two of these trusts while, due to data availability, statistical analysis and 
visualisation of patient pathways were used with the remaining two.    
4.3. Hypothesis three: a common reference point 
The clearest example of debate about change was in the final project meeting between the ED 
clinicians and the AST lead.   Both parties had the patient’s interest at heart yet both took radically 
different views on how to manage emergency stroke patients.  Here the model results both for 
treatment rates and patient disability were the most useful.  Although some consultants reacted 
negatively to the proposals, their objections used the model results as a common reference point in 
their arguments; for example, “are those disability results real in the pre-alert scenario”.  This 
prompted a discussion of the clinical assumptions included within the model and provided a forum 
for clinicians with concerns to air their views.  This evidence agrees with our initial assumption about 
the model acting as a common reference point. 
The exact influence of this imposed structure on the success of implementation is difficult to discern 
from a single case study.   However, we propose that the process of setting up a meeting with ED 
and presenting quantified results may have helped change clinicians’ attitudes.  Some evidence of 
this can be seen in the comments from two ED clinicians towards the end of the meeting.  In 
particular, they appreciated the time taken to perform the analysis and meet with them for a 
discussion as opposed to 'the usual approach of specialities e-mailing a demand'. In other words the 
more collaborative nature of our engagement within their organisation persuaded them to positively 
consider the changes. 
5. Discussion 
This paper makes two contributions to the DES and OR literature.  Firstly, evidence of the 
effectiveness of simulation in improving health systems is provided through our evaluation of the 
impact of implementing the results of a DES study in emergency stroke care.  Secondly, we compare 
the research team’s assumptions about how the intervention was supposed to work to what actually 
happened to assist planning of OR projects to maximise influence and impact.  We report these 
contributions in this section as follows.  Initially we summarise the utility of the simulation by 
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comparing the actual outcomes of implementation to those predicted.  Then we critique the three 
assumptions regarding the use of modelling and implementation set out in the introduction.  We 
close the section with a discussion of the strengths and limitations of our evaluation. 
5.1. Model utility and validity 
Our results clearly demonstrate that improvement occurred in the hospital’s management of 
emergency stroke patients over the timescale of the project.  More stroke patients are treated in 
shorter periods of time, particularly after phase 2 of implementation where the new thrombolysis 
rate represents a three-fold increase in the number of treated stroke patients under the age of 80.  
These improvements, falling into the middle of the range predicted by our model, are substantially 
higher than other recent thrombolysis improvement initiatives [47, 48].  We also observed a gradual 
growth in the proportion of patients treated as opposed to a step change, due to a dissemination 
effect where paramedic pre-alerting rose gradually from around 25-30% in the latter part of  2012 to 
60-70% in 2013.   
Although we had no over 80s population to compare to pre-implementation we know that these 
patients will also benefit from the more responsive process post-implementation.  As average 
treatment time approximately halved we can also expect that more over 80s patients are treated 
than would have been.  Our model predicted that treatment of the over 80s would increase from 7 
to 31 patients per year using the paramedic pre-alert system.  
We used a conservative approach to confirm improvement by including the period in which the 
simulation study was conducted within the pre-implementation period.  It is noteworthy that the 
thrombolysis rate observed pre-implementation is skewed by the period in which the simulation 
study was conducted.  Our explanation of the during effect relates to the nature of the change.  
Implementation relates not only to hospital protocols, but also the relationships that the specialist 
stroke nurses have with their colleagues in ED and radiology.  Anecdotally they reported an 
improvement in these relationships through their participation in the study.  This in effect means 
that the triage referral system was implemented, to some extent, before the official sign off in the 
ED. 
The utility of the model was affected by our decision not to incorporate the incidence of SIH 
resulting from thrombolysis.  This decision was made with user involvement, although this figure 
turned out to be influential with the ED clinicians not involved in the study.  As expected the actual 
incidence of SIH pre and post implementation was similar and within expected limits from the 
evidence base [18].   In terms of the validity of our model, the decision not to explicitly incorporate 
SIH as an outcome measure is legitimate; however, it did cause credibility issues with a group of ED 
clinicians and serves as a clear reminder of the difference between validity and credibility [49]. 
5.2. Did the simulation study work as expected? 
To effectively evaluate a modelling intervention the underlying assumptions about how the 
intervention was supposed to work must be surfaced [13].   Table 2 summarises the three 
assumptions outlined in the introduction to the research against evaluation findings and several 
propositions refined on the basis of the evaluation. 
Our first hypothesis was that involvement of stakeholders in conceptual modelling aids the 
relevance, transparency and credibility of results and hence chances of implementation.   We 
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involved representatives from both the ED and AST at the beginning of the study.  However, the 
views expressed by the ED clinical lead were not fully representative of the larger clinical group, a 
finding which surfaced substantially later in the project.  Therefore we neglected to include a key 
output (risk of SIH) in our model.  The impact of this decision on model credibility demonstrates that 
involvement in conceptual modelling can indeed be a critical component of implementation.  We 
note, however, that in practice the stakeholder group involved in conceptual modelling has to be 
limited in size; hence it is difficult to judge the representativeness of the wider stakeholders.  Our 
experience at the other hospitals, where ED was more extensively involved throughout, also 
suggests that selection bias is in play.  The representatives from ED who wished to be involved in the 
project were those with the most positive views towards the treatment.  Although selection bias in 
the main project group will be difficult to eliminate entirely it is likely that members of the project 
group will be aware to some extent of colleague’s views.  A simple approach within OR 
interventions, therefore, is interview stakeholders individually and ask what social or political factors 
affect performance improvement.  This approach is similar to initial stages of SSM i.e. investigating 
the social norms and roles within an organisation.  This line of questioning may also help identify key 
individuals whose views are not currently represented by the project group and that could be invited 
to join.   
In contrast to the ED and AST, the ambulance service was not involved at all during conceptual 
modelling or the larger intervention.   However, results were welcomed with enthusiasm.  A possible 
explanation of this is that ambulance services are highly focussed on continual improvements in 
responsiveness.  The changes recommended by the study reinforced these organisational objectives 
and the manner in which the ambulance trust conceptualised problems. Therefore, although 
involvement in conceptual modelling was not essential in this case, inclusion of the ambulance trust 
in discussion of results was essential. In the ED several senior clinicians were more focussed on the 
medicine than process.   Involvement of these individuals in debate around results was also essential 
as it provided an opportunity to develop their focus on process improvement.  This latter hypothesis 
also provides a practical workaround for the selection bias issue for the main stakeholder group 
involved right throughout an intervention.   
17 
 
Table 2: Hypotheses about the modelling process,  findings and post-evaluation propositions 
Hypotheses Findings Post-evaluation propositions 
1. If stakeholders are involved in conceptual 
modelling (CM) then the relevance, transparency 
and credibility of results to stakeholders are 
increased. 
1.1 ED were involved in CM right at the beginning; 
however, it proved difficult to involve a 
representative group of clinicians 
 
1.2 Individual ED clinicians not involved in CM were 
critical of the evidence base for thrombolysis, but 
once involved in discussion of results were able to 
reach a consensus that changes should be 
implemented   
 
1.3 The ambulance service was not involved in CM, 
but were keen to implement results 
 
 If stakeholders that are representative of the 
wider organisation are involved in CM then the 
relevance, transparency and credibility of results 
to stakeholders are increased. 
  
 If stakeholders who have not been involved in CM 
are later involved in discussion of results then 
their focus on process improvement can be 
developed or reinforced.     
2. If stakeholders can be engaged by VIS in validation 
and experimentation then the resulting model 
transparency and development of working 
relationships increase the use of results. 
2.1 Little evidence that VIS increased engagement 
within the project; more useful for validation of 
model logic. 
 
2.2 VIS effective for demonstrating the model to 
other hospitals and securing new project work 
 
 
 If stakeholders are unfamiliar with modelling then 
using VIS in validation and experimentation 
improves initial engagement and buy-in; but to 
improve the use of model outputs [in a clinical 
setting] requires the presentation of results in a 
more conventional scientific form. 
 
 
3. If stakeholders with competing interests are 
engaged in a modelling project then debate about 
implementation is structured by the model acting 
as a common reference point. 
3.1 The model’s clinical assumptions and results were 
used as a common reference point to debate 
post-treatment disability. 
 
3.2 ED clinicians were more willing to consider the 
results due given the manner in which the study 
was conducted  
 If a common forum for the mutual exchange of 
information and experiential knowledge can be 
developed then the uptake and integration of 
different forms of knowledge are increased. 
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Our second hypothesis concerned the use of VIS to increase stakeholder engagement.  We found 
little evidence of this within the project.  In fact many clinical stakeholders were more interested in 
the batch run results presented using simple charts.  .  The main use of VIS, therefore, was as part of 
model validation i.e. stepping through model logic with the AST.   A possible explanation is that the 
presentation of results in medical science, i.e. tables of summary statistics and measures of 
accuracy, is more akin to batch run results in simulation than process animations.  The more 
‘scientific’ appearance of these results in this context was therefore more engaging for clinicians.   
Unexpectedly, the model was much more engaging to stakeholders outside of the project.  VIS was 
particularly helpful in engaging clinicians and managers from elsewhere who heard about the work 
through the local NHS Stroke Network and were keen to replicate it at their hospitals. This less-
tangible aspect of dissemination, if not implementation, is perhaps overlooked when discussing the 
impacts of a simulation study.  Thus we propose an alternative formulation of our original 
hypothesis about VIS: if stakeholders are unfamiliar with modelling then using VIS in validation and 
experimentation improves initial engagement or buy-in to simulation. Further research may wish to 
consider if these types of effects are specific to modelling techniques that lend themselves to 
animation or if this is a more general benefit across modelling. 
Our third hypothesis concerns using a model to provide stakeholders with a common reference 
point to debate change, an idea that is well documented within OR.  In our study the model 
facilitated the discussion of implementation by providing a structure to scrutinise the clinical 
assumptions that underpinned the results.  The validity of these assumptions and objections were 
debated at length within the ED clinician meeting.   The model acted as a reference point for this 
discussion (for example, “are those disability results real?” and “in your model you pre-alert the ED, 
wouldn’t it be better to…”) and helped progress to be made in reaching a final decision on 
implementation within the ED, despite the objections of some staff members. Outside of the group 
concerned about the clinical effectiveness of thrombolysis, engaging the ED team in a collaborative 
manner that was unusual to them with a model also helped with the credibility of 
recommendations.  Hence an additional proposition for implementation theory may be the idea of a 
collaborative forum for the mutual exchange of information and experiential knowledge.  If this can 
be developed within a modelling project then the uptake and integration of different forms of 
knowledge is increased. 
In summary, our DES study was able to inform and support a dramatic improvement in both the 
treatment rate for stroke patients and the speed with which the treatment was delivered, but the 
modelling process did not always work as expected.  In particular, we draw attention to the practical 
difficulties we faced with gaining a representative understanding of ED’s view on the problem and 
the use of VIS as an initial buy-in tool rather than a device for continual engagement. 
5.3. Limitations 
While other studies of implementation have used qualitative methods only [e.g. 8, 50], a particular 
strength of this evaluation is the use of both the quantitative evaluation of system efficiency and 
qualitative critique of the process that led to implementation.  However, a weakness is that the 
qualitative study is based purely on the lead modeller’s field notes: providing only a single 
perspective which may be subject to some bias.  A more systematic approach would incorporate an 
independent researcher to develop and document the evaluation throughout.  Such evaluations 
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might make use of systematic methods extracting group decision development process data [51], 
frameworks for investigating implementation processes such as the Promoting Action on Research 
Implementation in Health Services (PARIHS) framework [52] and sampling of process measures 
informed by the principles of Improvement Science [53] 
Similarly we note that we framed the evaluation in terms of the research team and the hospital and 
did not include users that were not directly involved [54] i.e. services users: both carers and patients.  
We found the tracking of disability measures post stroke unfeasible for this project and even if they 
were included we would not gain an understanding of the perceived quality of care and outcomes.  
A possible way to mitigate this in future studies may be the involvement of service user 
representatives throughout a simulation study and during implementation of its results [55].   
6. Conclusions 
Most published case studies of DES in health do not provide any discussion of the implementation of 
study results [5] or any structured evaluation.  In order to provide an evidence base of the impact of 
simulation modelling in practical applications it is essential to publish accounts of implementation.   
One way to build this evidence base is for case study authors to provide an evaluation of 
implementation (or improved understanding) in which the modelling process assisted, which may 
involve longer timescales than anticipated.  To contribute to this growing area, this paper presents 
an evaluation of implementing the results of a DES study of emergency stroke care.  The results 
demonstrate that the simulation did contribute to improvement, but change was difficult and the 
intervention did not always match the research team’s assumptions about how things would work.   
This ‘not matching’ has enabled the theories to be refined and added to in a way that can inform 
future modelling practice and help DES studies to better address the knowledge deficits that can 
have such a negative impact on health outcomes.  In order to minimize interpretation bias and 
create generalizable knowledge to improve simulation interventions, more systematic prospective 
evaluation is needed; this is likely to include specialist knowledge different to that of a typical expert 
in simulation.  
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